188 related articles for article (PubMed ID: 11301561)
1. Pharmacokinetic and pharmacodynamic characteristics and safety of inhaled albuterol enantiomers in healthy volunteers.
Gumbhir-Shah K; Kellerman DJ; DeGraw S; Koch P; Jusko WJ
J Clin Pharmacol; 1998 Dec; 38(12):1096-106. PubMed ID: 11301561
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and pharmacodynamics of single oral doses of albuterol and its enantiomers in humans.
Boulton DW; Fawcett JP
Clin Pharmacol Ther; 1997 Aug; 62(2):138-44. PubMed ID: 9284849
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and pharmacodynamics of cumulative single doses of inhaled salbutamol enantiomers in asthmatic subjects.
Gumbhir-Shah K; Kellerman DJ; DeGraw S; Koch P; Jusko WJ
Pulm Pharmacol Ther; 1999; 12(6):353-62. PubMed ID: 10587476
[TBL] [Abstract][Full Text] [Related]
4. The therapeutic ratio of R-albuterol is comparable with that of RS-albuterol in asthmatic patients.
Lötvall J; Palmqvist M; Arvidsson P; Maloney A; Ventresca GP; Ward J
J Allergy Clin Immunol; 2001 Nov; 108(5):726-31. PubMed ID: 11692096
[TBL] [Abstract][Full Text] [Related]
5. Preliminary pharmacokinetic study of ibuprofen enantiomers after administration of a new oral formulation (ibuprofen arginine) to healthy male volunteers.
Fornasini G; Monti N; Brogin G; Gallina M; Eandi M; Persiani S; Bani M; Della Pepa C; Zara G; Strolin Benedetti M
Chirality; 1997; 9(3):297-302. PubMed ID: 9176996
[TBL] [Abstract][Full Text] [Related]
6. Preferential pulmonary retention of (S)-albuterol after inhalation of racemic albuterol.
Dhand R; Goode M; Reid R; Fink JB; Fahey PJ; Tobin MJ
Am J Respir Crit Care Med; 1999 Oct; 160(4):1136-41. PubMed ID: 10508799
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and tolerability of formoterol in healthy volunteers after a single high dose of Foradil dry powder inhalation via Aerolizer.
Lecaillon JB; Kaiser G; Palmisano M; Morgan J; Della Cioppa G
Eur J Clin Pharmacol; 1999 Apr; 55(2):131-8. PubMed ID: 10335908
[TBL] [Abstract][Full Text] [Related]
8. Comparison of bronchodilator responses of levosalbutamol and salbutamol given via a pressurized metered dose inhaler: a randomized, double blind, single-dose, crossover study.
Jantikar A; Brashier B; Maganji M; Raghupathy A; Mahadik P; Gokhale P; Gogtay J; Salvi S
Respir Med; 2007 Apr; 101(4):845-9. PubMed ID: 17276051
[TBL] [Abstract][Full Text] [Related]
9. Hemodynamic effects of reboxetine in healthy male volunteers.
Denolle T; Pellizzoni C; Jannuzzo MG; Poggesi I
Clin Pharmacol Ther; 1999 Sep; 66(3):282-7. PubMed ID: 10511064
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and extrapulmonary beta 2 adrenoceptor activity of nebulised racemic salbutamol and its R and S isomers in healthy volunteers.
Lipworth BJ; Clark DJ; Koch P; Arbeeny C
Thorax; 1997 Oct; 52(10):849-52. PubMed ID: 9404370
[TBL] [Abstract][Full Text] [Related]
11. [Studies on the pharmacokinetics and relative bioavailability of salbutamol aerosol in healthy volunteers].
Du XL; Zhu Z; Fu Q; Li DK; Xu WB
Yao Xue Xue Bao; 2001 Aug; 36(8):616-20. PubMed ID: 12579942
[TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetics of (R)-albuterol and (S)-albuterol in pediatric patients aged 4-11 years with asthma.
Maier G; Rubino C; Hsu R; Grasela T; Baumgartner RA
Pulm Pharmacol Ther; 2007; 20(5):534-42. PubMed ID: 16891136
[TBL] [Abstract][Full Text] [Related]
13. Human pharmacology of the methamphetamine stereoisomers.
Mendelson J; Uemura N; Harris D; Nath RP; Fernandez E; Jacob P; Everhart ET; Jones RT
Clin Pharmacol Ther; 2006 Oct; 80(4):403-20. PubMed ID: 17015058
[TBL] [Abstract][Full Text] [Related]
14. Low-dose levalbuterol in children with asthma: safety and efficacy in comparison with placebo and racemic albuterol.
Milgrom H; Skoner DP; Bensch G; Kim KT; Claus R; Baumgartner RA;
J Allergy Clin Immunol; 2001 Dec; 108(6):938-45. PubMed ID: 11742271
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of reboxetine enantiomers in the dog.
Frigerio E; Benecchi A; Brianceschi G; Pellizzoni C; Poggesi I; Strolin Benedetti M; Dostert P
Chirality; 1997; 9(3):303-6. PubMed ID: 9176997
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and relative bioavailability of salbutamol metered-dose inhaler in healthy volunteers.
Du XL; Zhu Z; Fu Q; Li DK; Xu WB
Acta Pharmacol Sin; 2002 Jul; 23(7):663-6. PubMed ID: 12100764
[TBL] [Abstract][Full Text] [Related]
17. The pharmacokinetics of levosalbutamol: what are the clinical implications?
Boulton DW; Fawcett JP
Clin Pharmacokinet; 2001 Jan; 40(1):23-40. PubMed ID: 11236808
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
Smith WB; Dowell JA; Pratt RD
Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
[TBL] [Abstract][Full Text] [Related]
19. Gender-related effects on metoprolol pharmacokinetics and pharmacodynamics in healthy volunteers.
Luzier AB; Killian A; Wilton JH; Wilson MF; Forrest A; Kazierad DJ
Clin Pharmacol Ther; 1999 Dec; 66(6):594-601. PubMed ID: 10613615
[TBL] [Abstract][Full Text] [Related]
20. Lack of effect of reboxetine on cardiac repolarization.
Fleishaker JC; Francom SF; Herman BD; Knuth DW; Azie NE
Clin Pharmacol Ther; 2001 Sep; 70(3):261-9. PubMed ID: 11557914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
